INDIANAPOLIS -- Eli Lilly announced Tuesday that it was ending testing on an experimental drug meant to battle Alzheimer’s disease.
The news comes after an independent researcher found that the drug, which is still in development, was unlikely to work on patients with early Alzheimer’s and dementia.
The company says they are ending the trial because it wasn’t working out, not because of any safety concerns from the testing.
Lilly says it plans to immediately begin working on another experimental Alzheimer’s drug.
MORE TOP STORIES | Teacher, student wounded when another student opened fire at Noblesville middle school | Science teacher Jason Seaman being called a hero for stopping school shooter | Noblesville teacher shot 3 times while stopping shooter released from the hospital | Family of girl wounded in Noblesville school shooting thanks everyone for prayers | Man found dead in tent in parking lot at Indianapolis Motor Speedway identified
Top Trending Videos
